The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more quickly and boosting the UK’s competitiveness for global clinical research.
UK MHRA · January 13, 2026
Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation
Original title: Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation
MHRA announces 2026 reforms to accelerate clinical trial assessments and improve UK competitiveness for global research.
Published by UK MHRA. HealthSignal links to the original document; the summary above is extracted from the source text.